Celsion Corporation (CLSN) financial statements (2020 and earlier)

Company profile

Business Address 997 LENOX DRIVE
LAWRENCEVILLE, NJ 08648
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1528244203743
Cash and cash equivalents7131139136
Short-term investments814132112437
Other undisclosed cash, cash equivalents, and short-term investments  0(0)   
Receivables1000000
Other undisclosed current assets0000001
Total current assets:1628245203844
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment    111
Intangible assets, net (including goodwill)1818232622(0)
Goodwill222222 
Intangible assets, net (excluding goodwill)1616212400(0)
Deposits noncurrent assets00 0000
Deferred costs    001
Deferred income tax assets2
Other noncurrent assets  0    
Other undisclosed noncurrent assets   02525(1)
Total noncurrent assets:2219232628281
Other undisclosed assets0000111
TOTAL ASSETS:38474831496746
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5665572
Accounts payable3333331
Accrued liabilities232222 
Employee-related liabilities     11
Deferred revenue1
Debt2  3440
Deferred revenue and credits11111
Contract with customer, liability1
Other undisclosed current liabilities     (1)2
Total current liabilities:86689105
Noncurrent Liabilities
Long-term debt and lease obligation99  265
Long-term debt, excluding current maturities89  265
Operating lease, liability1
Liabilities, other than long-term debt79151617174
Deferred revenue and credits23344
Deferred revenue1
Other liabilities 000000
Business combination, contingent consideration, liability6913131414
Other undisclosed noncurrent liabilities 2   00
Total noncurrent liabilities:1620151619249
Total liabilities:24262124293414
Stockholders' equity
Stockholders' equity attributable to parent, including:1521277203332
Common stock000000 
Treasury stock, value(0)(0)(0)(0)(1)(2)(2)
Additional paid in capital305294288248240230203
Accumulated other comprehensive income (loss)00(0) (0)(0)(0)
Accumulated deficit(291)(274)(262)(241)(218)(195)(169)
Warrants and rights outstanding      3,268,013
Other undisclosed stockholders' equity attributable to parent      (3,268,013)
Total stockholders' equity:1521277203332
TOTAL LIABILITIES AND EQUITY:38474831496746

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenue, net11111
Gross profit:1111101
Operating expenses(21)(22)(19)(21)(21)(25)(16)
Other undisclosed operating income     0 
Operating loss:(21)(21)(18)(21)(21)(25)(15)
Nonoperating income (expense)2(1)(2)(1)(2)(1)7
Investment income, nonoperating100000(0)
Interest and debt expense(1)(1)(0)(1)(1)(1)(1)
Loss from continuing operations before equity method investments, income taxes:(20)(23)(20)(23)(24)(27)(9)
Other undisclosed income from continuing operations before income taxes11     
Loss from continuing operations before income taxes:(19)(22)(20)(23)(24)(27)(9)
Income tax benefit210     
Net loss:(17)(12)(20)(23)(24)(27)(9)
Other undisclosed net income attributable to parent  01111
Net loss attributable to parent:(17)(12)(20)(22)(22)(25)(8)
Preferred stock dividends and other adjustments      (5)
Other undisclosed net loss available to common stockholders, basic  (0)    
Net loss available to common stockholders, diluted:(17)(12)(21)(22)(22)(25)(13)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(17)(12)(20)(23)(24)(27)(9)
Other comprehensive income   0000
Comprehensive loss:(17)(12)(20)(23)(24)(27)(9)
Other undisclosed comprehensive income, net of tax, attributable to parent0001111
Comprehensive loss, net of tax, attributable to parent:(17)(12)(20)(22)(22)(25)(8)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: